Your browser doesn't support javascript.
loading
Cardiovascular diseases in Paralympic athletes.
Pelliccia, Antonio; Quattrini, Filippo M; Squeo, Maria Rosaria; Caselli, Stefano; Culasso, Franco; Link, Mark S; Spataro, Antonio; Bernardi, Marco.
Afiliação
  • Pelliccia A; Institute of Sport Medicine and Science, Rome, Italy.
  • Quattrini FM; Institute of Sport Medicine and Science, Rome, Italy.
  • Squeo MR; Institute of Sport Medicine and Science, Rome, Italy.
  • Caselli S; Institute of Sport Medicine and Science, Rome, Italy.
  • Culasso F; Department of Human Physiology and Pharmacology, University Sapienza, Rome, Italy.
  • Link MS; TUFTS Medical Center, Boston, Massachusetts, USA.
  • Spataro A; Institute of Sport Medicine and Science, Rome, Italy.
  • Bernardi M; Department of Human Physiology and Pharmacology, University Sapienza, Rome, Italy Italian Paralympic Committee, Rome, Italy.
Br J Sports Med ; 50(17): 1075-80, 2016 Sep.
Article em En | MEDLINE | ID: mdl-27231335
ABSTRACT

BACKGROUND:

Sport participation (SP) of individuals with impairments has recently grown exponentially. Scarce scientific data, however, exist regarding cardiovascular (CV) risk associated with competitive SP.

OBJECTIVE:

Assessing the prevalence of CV abnormalities and the risk for SP in Paralympic athletes (PA).

METHODS:

PA (n=267; 76% men), aged 35±9 years, engaged in 18 sport disciplines, with a spectrum of lesions including spinal cord injury (paraplegia and spina bifida) (n=116); amputation, poliomyelitis, cerebral palsy and other neuromuscular and/or skeletal disorders (Les autres) or visual impairment (n=151) entered the study. CV evaluation included history, PE, 12-lead and exercise ECG, echocardiography. Of these, 105 participated in ≥2 consecutive games, and had evaluations available over a 6±4 year follow-up.

RESULTS:

Structural CV abnormalities were identified in 33 athletes (12%), including arrhythmogenic cardiomyopathies in 3, aortic root dilation in 3, valvular diseases in 7 (mitral valve prolapse in 4, bicuspid aortic valve in 3) and systemic hypertension in 11 (4%). In addition, ventricular (polymorphic, couplets or non-sustained ventricular tachycardia) or supraventricular tachyarrhythmias (atrial flutter, paroxysmal atrial fibrillation or SVT) were identified in 9 others. Over a 6-year follow-up, 6 of the 105 athletes (6%) developed CV diseases, including dilated cardiomyopathy in 1 and systemic hypertension in 5.

CONCLUSIONS:

PA present an unexpected high prevalence of CV abnormalities (12%), including a non-trivial proportion of diseases at risk for sudden death (2%), such as arrhythmogenic cardiomyopathies and dilated aortic root. This observation suggests that tailored recommendations for preparticipation screening and safe SP in this special athletic population are timely and appropriate.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Esportes para Pessoas com Deficiência Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Esportes para Pessoas com Deficiência Idioma: En Ano de publicação: 2016 Tipo de documento: Article